Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Gilead Sciences Inc (GILD)

79.4 -1.29 (-1.6%)

02-22 16:00

Open:

80.73

Pre. Close:

80.69

High:

81.13

Low:

79.18

Volume:

8,382,198

Market Cap:

103718M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

81.277 - 81.738

81.738 - 82.239

Low:

77.936 - 78.447

78.447 - 79.003

Close:

78.439 - 79.325

79.325 - 80.287

Technical analysis  (as of: 2018-02-22 5:01:19 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 98.55     One year: 104.58

Support:

Support1: 76.02    Support2: 63.25

Resistance:

Resistance1: 84.38    Resistance2: 89.54

Pivot:

80.69

Moving Averages:

MA(5): 80.66     MA(20): 81.84

MA(100): 77.56     MA(250): 73.61

MACD:

MACD(12,26): 0.28     Signal(12,26,9): 0.67

%K %D:

%K(14,3): 40.53     %D(3): 39.31

RSI:

RSI(14): 46.84

52-Week:

High: 89.54  Low: 63.76  Change(%): 13.5

Average Vol(K):

3-Month: 891650  10-Days 879872

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GILD has closed above bottom band by 27.5%. Bollinger Bands are 19.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 22 Feb 2018 21:56:15 GMT
Gilead Sciences Announces Senior Management Change

Thu, 22 Feb 2018 12:30:45 GMT
Gilead signs $3 bln licensing deal for Sangamo's gene-editing platform

Sat, 17 Feb 2018 14:57:00 GMT
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Wed, 07 Feb 2018 11:26:15 GMT
Gilead Sciences Inc. Delivers Deja Vu in the Fourth Quarter

Tue, 20 Feb 2018 15:32:42 GMT
Merck Falls After $2.54 Billion Gilead Verdict Is Tossed

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

1308.00

Shares Float (M)

1300.96

% Held by Insiders

% Held by Institutions

76.30

Shares Short (K)

22495

Shares Short Prior Month (K)

19600

Stock Financials

EPS

8.540

EPS Est. Current Year

8.790

EPS Est. Next Year

7.340

EPS Est. Next Quarter

1.900

Forward EPS

6.588

Book Value (p.s.)

4.250

PEG Ratio

-1.53

Profit Margin

18.96

Operating Margin

54.58

Return on Assets (ttm)

7.7

Return on Equity (ttm)

24.7

Qtrly Rev. Growth

-18.7

Gross Profit (p.s.)

16.618

Sales Per Share

EBITDA (p.s.)

11.878

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

9.30

P/E Growth Ratio

-0.02

P/BV

18.68

P/S

5205905920.00

P/CF

Dividend Yield

0.04

Dividends & Splits

Dividend

2.825

Dividend Pay Date

2017-12-28

Ex-Dividend Date

2017-12-14

Forward Dividend

2.280

Last Split Date

2013-01-28

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.